Description

With the increasing prevalence and burden of atrial fibrillation (AFib), clinicians require education on the importance of anticoagulation in reducing the incidence of AFib-related stroke, current methods to optimize warfarin therapy, and the potential impact of emerging treatment options.

Learning Objectives

At the end of this educational activity, participants should be able to:

  • Review the etiology of atrial fibrillation (AFib) and its prevalence in the United States
  • Summarize the burden of AFib to society and individuals
  • Understand and recognize risk factors including patient characteristics for AFib and morbidities associated with AFib
  • Examine proper determinants and steps for diagnosis of AFib

Target Audience

Medical Oncologists, NPs and PAs with oncology specialty

Faculty

  • Jeremy N. Ruskin, MD
    Director, Cardiac Arrhythmia Service, MGH
    Associate Professor of Medicine, Harvard Medical School

CME Information

Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education; however, this event is no longer accredited.

 

 

Credit Designation
This event is no longer accredited.

Planners

The following planners of this activity have indicated that neither they nor their families have a significant financial interest or affiliation with the manufacturer of any commercial products or provider of commercial services:

Robert J. Birnbaum, MD, PhD: Planner

John A. Fromson, MD: Planner, reviewer

Anan Nathif, EdM: Planner

Tristan Gorrindo, MD:Planner

Hardware/Software Specifications: 

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements:
Windows PC:
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh:
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

Speakers

 

The following speakers and/or planners have reported receiving something of value from a company whose product may be germane to the content of their presentations:

Jeremy N. Ruskin, MD

Research Support

Boston Scientific, Medtronic, and St. Jude Medical.

Advisory/Consulting

ARYx, Astellas/Cardiome, Biosense Webster, CardioInsight, Medtronic, Pfizer, Portola, Sanofi Aventis, and Sequel.

Clinical Oversight Committee

CardioFocus.

Scientific Steering Committee

CryoCath and Pfizer.

Last updated: 7/27/2010